10 best weight loss drug stocks gain traction, led by Eli Lilly's Mounjaro and Zepbound with a 148% share increase since early March 2023.

10 Best Weight Loss Drug Stocks are gaining traction, with Americans seeking one-stop solutions for weight loss. Eli Lilly's Mounjaro and Zepbound drugs have led to a 148% increase in the company's shares since early March 2023. Morgan Stanley predicts the weight loss drug industry could see a non-tech trillion-dollar valuation. Other notable stocks include Novo Nordisk with a 73% increase and Roche.